SG148860A1 - Stereospecific reduction of sapogen-3-ones - Google Patents

Stereospecific reduction of sapogen-3-ones

Info

Publication number
SG148860A1
SG148860A1 SG200703083-6A SG2007030836A SG148860A1 SG 148860 A1 SG148860 A1 SG 148860A1 SG 2007030836 A SG2007030836 A SG 2007030836A SG 148860 A1 SG148860 A1 SG 148860A1
Authority
SG
Singapore
Prior art keywords
sapogen
ones
stereospecific reduction
stereospecific
reduction
Prior art date
Application number
SG200703083-6A
Other languages
English (en)
Inventor
Philip James Gunning
Peter David Tiffin
Original Assignee
Phytopharm Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0225106A external-priority patent/GB0225106D0/en
Priority claimed from GB0301505A external-priority patent/GB0301505D0/en
Application filed by Phytopharm Plc filed Critical Phytopharm Plc
Publication of SG148860A1 publication Critical patent/SG148860A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
SG200703083-6A 2002-10-28 2003-04-28 Stereospecific reduction of sapogen-3-ones SG148860A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0225106A GB0225106D0 (en) 2002-10-28 2002-10-28 Synthesis of 3 hydroxy-5 -steroids
GB0301505A GB0301505D0 (en) 2003-01-22 2003-01-22 Stereospecific synthesis of sapogenins

Publications (1)

Publication Number Publication Date
SG148860A1 true SG148860A1 (en) 2009-01-29

Family

ID=32178884

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200703083-6A SG148860A1 (en) 2002-10-28 2003-04-28 Stereospecific reduction of sapogen-3-ones

Country Status (17)

Country Link
US (1) US7718792B2 (ko)
EP (1) EP1558627B1 (ko)
JP (1) JP4607758B2 (ko)
KR (1) KR101092150B1 (ko)
AT (1) ATE459636T1 (ko)
AU (1) AU2003224308A1 (ko)
BR (1) BR0315746A (ko)
CA (1) CA2503899C (ko)
DE (1) DE60331572D1 (ko)
ES (1) ES2342274T3 (ko)
MX (1) MXPA05004494A (ko)
PL (1) PL210114B1 (ko)
PT (1) PT1558627E (ko)
RU (1) RU2326890C2 (ko)
SG (1) SG148860A1 (ko)
TW (1) TWI334781B (ko)
WO (1) WO2004037845A1 (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
KR101130212B1 (ko) * 2002-03-27 2012-04-13 파이토팜 피엘씨 사포게닌 및 그 유도체의 치료 방법 및 사용법
GB0409567D0 (en) * 2004-04-28 2004-06-02 Phytopharm Plc Chemical compounds
WO2009132478A1 (en) * 2008-04-30 2009-11-05 Phytopharm Plc Synthesis of timosaponin bii
CN106810592A (zh) * 2016-11-29 2017-06-09 杭州裕美生物科技有限公司 一种4‑烯‑3,6‑二酮甾体的合成工艺

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150336A (en) * 1995-05-29 2000-11-21 Pfizer Inc. Steroidal glycosides

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB736818A (en) 1951-12-28 1955-09-14 Glidden Co Improvements in or relating to preparation of 3-keto steroids having cis junction of rings a and b
GB763301A (en) 1953-09-05 1956-12-12 Farmaceutici Italia Process for the reduction of í¸-3-keto-steroids to 5-ª -dihydro-steroids
DE2257132C3 (de) * 1972-11-18 1982-05-13 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Reduktion von 3-Ketosteroiden
RU94046294A (ru) * 1992-06-26 1996-10-10 Пфайзер Инк. (US) Стероидные гликозиды для лечения гиперхолестеринэмии
CA2180148A1 (en) 1993-12-28 1995-07-06 Michael Paul Deninno Hypocholesterolemic agents
WO1996009827A2 (en) * 1994-09-20 1996-04-04 Pfizer Inc. Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor
CN1198622C (zh) * 1998-03-26 2005-04-27 植物药物公共有限公司 用于治疗阿尔茨海默病的甾类皂苷及其衍生物
GB9923076D0 (en) 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB0000228D0 (en) 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
GB0107822D0 (en) 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150336A (en) * 1995-05-29 2000-11-21 Pfizer Inc. Steroidal glycosides

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EPI- SARSASAPOGENIN AND EPI-SMILAGENIN: TWO SAPOGENINS ISOLATED FROM THE RUMEN CONTENT OF SHEEP INTOXICATED BY BRACHIARIA DECUMBENS *
STEROLS. LVI. SARSASAPOGENIN DERIVATIVES. EPI- SARSASAPOGENIN *

Also Published As

Publication number Publication date
CA2503899C (en) 2011-12-20
KR20050090379A (ko) 2005-09-13
PL210114B1 (pl) 2011-12-30
WO2004037845A1 (en) 2004-05-06
TW200406215A (en) 2004-05-01
PL376791A1 (pl) 2006-01-09
RU2005111593A (ru) 2006-05-10
US20060041119A1 (en) 2006-02-23
EP1558627A1 (en) 2005-08-03
MXPA05004494A (es) 2005-07-26
BR0315746A (pt) 2005-09-06
KR101092150B1 (ko) 2011-12-12
US7718792B2 (en) 2010-05-18
JP4607758B2 (ja) 2011-01-05
JP2006507360A (ja) 2006-03-02
CA2503899A1 (en) 2004-05-06
EP1558627B1 (en) 2010-03-03
PT1558627E (pt) 2010-05-06
ATE459636T1 (de) 2010-03-15
TWI334781B (en) 2010-12-21
RU2326890C2 (ru) 2008-06-20
ES2342274T3 (es) 2010-07-05
DE60331572D1 (de) 2010-04-15
AU2003224308A1 (en) 2004-05-13

Similar Documents

Publication Publication Date Title
AU2003285934A1 (en) Analogs and prodrugs of buprenorphine
SG145694A1 (en) Novel compounds
SG143985A1 (en) Quinolinone derivatives
HK1070369A1 (en) Sodium channel blockers
SG147409A1 (en) Amide derivatives
HK1077762A1 (zh) TFGß[轉化生長因子]的抑制劑
AU2003248122A1 (en) Sodium channel inhibitor
SG148182A1 (en) Antiloading compositions and methods of selecting same
IL165475A0 (en) Nitrooxyderivatives of eyclooxygenase-2 inhibitors
AU2003290592A1 (en) Antitumor benzoylsulfonamides
AU2003217600A8 (en) Microbial production of pyruvate and other metabolites
TW200508233A (en) Chk-1 inhibitors
AUPS329602A0 (en) Fertilisation of soil
AU2003227457A1 (en) Comparison of source files
SG148860A1 (en) Stereospecific reduction of sapogen-3-ones
MY143244A (en) Calcilytic compounds
AU2003295790A8 (en) Modulation of iap-like expression
AU2003290763A8 (en) Modulation of jumonji expression
AU2003240990A1 (en) Generation of synthetic speech
AU2003217754A1 (en) New methods of using antiangiogenic agents
AU2003238034A1 (en) Novel use of imidazotriazinones
GB0205327D0 (en) compounds
AU2003294373A8 (en) Modulation of tek expression
PL356853A1 (en) Application of bacteriphages
AU2003280985A1 (en) Regulation of human tripeptidyl peptidase ii